These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10355531)

  • 1. Positive staining for p53 and expression of c-erbB-2 in endosalpinx hyperplasia: analysis of 48 cases and review of literature.
    Rabczyński JK; Kochman AT
    Neoplasma; 1999; 46(1):31-4. PubMed ID: 10355531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cancer of the fallopian tube with transitional differentiation. Clinical and pathological assessment of 6 cases.
    Rabczyński JK; Kochman AT
    Neoplasma; 1999; 46(2):128-31. PubMed ID: 10466438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer.
    Barbati A; Cosmi EV; Sidoni A; Collini P; Porpora MG; Ferri I; Lüthy M; Lauro V; Bucciarelli E
    Anticancer Res; 1997; 17(1A):401-5. PubMed ID: 9066684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
    Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
    O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
    Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
    Hu WF; Liu MQ; Zhao Q
    Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical study of PCNA, p53 gene product and c-erbB-2 gene product in endometrial carcinoma].
    Miyazaki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Apr; 48(4):269-76. PubMed ID: 8936111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression.
    Kerr KM; Carey FA; King G; Lamb D
    J Pathol; 1994 Dec; 174(4):249-56. PubMed ID: 7884586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical co-expression of c-erbb-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast.
    Sharma BK; Ray A; Kaur S; Gupta S
    Indian J Exp Biol; 1999 Mar; 37(3):223-7. PubMed ID: 10641149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
    Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
    Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
    Temmim L; Baker H; Sinowatz F
    Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas.
    de Krijger RR; van der Harst E; van der Ham F; Stijnen T; Dinjens WN; Koper JW; Bruining HA; Lamberts SW; Bosman FT
    J Pathol; 1999 May; 188(1):51-5. PubMed ID: 10398140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.
    Kamel D; Pääkkö P; Nuorva K; Vähäkangas K; Soini Y
    J Pathol; 1993 May; 170(1):67-72. PubMed ID: 8100854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
    Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
    Wei Z; Wu Y; Zhai Z
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical study of c-erbB-2 and p53 protein in breast papillomatosis and its malignant transformation].
    Tian Y; Li S; Fu X
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):342-5. PubMed ID: 10920912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri.
    Holm R; Abeler VM; Skomedal H; Nesland JM
    Zentralbl Pathol; 1993 Jun; 139(2):153-6. PubMed ID: 8103676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.